| [1] |
曹正国, 高雅, 曾宇. 基于2018年牙周病国际新分类的重度牙周炎临床应用实践[J]. 口腔医学研究, 2023, 39(11):943-951.
doi: 10.13701/j.cnki.kqyxyj.2023.11.001
|
| [2] |
Herrera D, Sanz M, Kebschull M, et al. Treatment of stage Ⅳ periodontitis: The EFP S3 level clinical practice guideline[J]. J Clin Periodontol, 2022, 49(Suppl 24): 4-71.
|
| [3] |
Sanz M, Herrera D, Kebschull M, et al. Treatment of stage Ⅰ-Ⅲ periodontitis-The EFP S3 level clinical practice guideline[J]. J Clin Periodontol, 2020, 47(Suppl 22): 4-60.
doi: 10.1111/jcpe.v47.s22
|
| [4] |
Haas AN, Furlaneto F, Gaio EJ, et al. New tendencies in non-surgical periodontal therapy[J]. Braz Oral Res, 2021, 35(Supp 2): e095.
doi: 10.1590/1807-3107bor-2021.vol35.0095
pmid: 34586209
|
| [5] |
王金良, 刘梦蝶, 谢丽敏, 等. 抗菌肽应用于不同牙周袋深度患牙的效果评估[J]. 中华老年口腔医学杂志, 2017, 15(5): 280-285.
|
| [6] |
Kumari S, Booth V. Antimicrobial peptide mechanisms studied by whole-cell deuterium NMR[J]. Int J Mol Sci, 2022, 23(5): 2740.
doi: 10.3390/ijms23052740
|
| [7] |
Li X, Zuo SY, Wang B, et al. Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides[J]. Molecules, 2022, 27(9): 2675.
doi: 10.3390/molecules27092675
|
| [8] |
魏岱旭, 龚海伦, 张旭维. 抗菌肽的生物合成及医学应用[J]. 合成生物学, 2022, 3(4): 709-727.
doi: 10.12211/2096-8280.2022-001
|
| [9] |
Dong ZY, Zhang XY, Zhang Q, et al. Anticancer mechanisms and potential anticancer applications of antimicrobial peptides and their nano agents[J]. Int J Nanomedicine, 2024, 19: 1017-1039.
doi: 10.2147/IJN.S445333
|
| [10] |
Su ZH, Yu HJ, Lv TT, et al. Progress in the classification, optimization, activity, and application of antimicrobial peptides[J]. Front Microbiol, 2025, 16: 1582863.
doi: 10.3389/fmicb.2025.1582863
|
| [11] |
Zhao JS, Wei Y, Xiong J, et al. A multiple controlled-release hydrophilicity minocycline hydrochloride delivery system for the efficient treatment of periodontitis[J]. Int J Pharm, 2023, 636: 122802.
doi: 10.1016/j.ijpharm.2023.122802
|
| [12] |
Teles FRF, Lynch MC, Patel M, et al. Bacterial resistance to minocycline after adjunctive minocycline microspheres during periodontal maintenance: A randomized clinical trial[J]. J Periodontol, 2021, 92(9): 1222-1231.
doi: 10.1002/jper.v92.9
|
| [13] |
Chen Y, Zhang YF, Wang XH, et al. Antibacterial activity and its mechanisms of a recombinant Funme peptide against Cronobacter sakazakii in powdered infant formula[J]. Food Res Int, 2019, 116: 258-265.
doi: 10.1016/j.foodres.2018.08.030
|
| [14] |
Luo Y, Song YZ. Mechanism of antimicrobial peptides: Antimicrobial, anti-inflammatory and antibiofilm activities[J]. Int J Mol Sci, 2021, 22(21): 11401.
doi: 10.3390/ijms222111401
|
| [15] |
Lee JK, Luchian T, Park Y. New antimicrobial peptide kills drug-resistant pathogens without detectable resistance[J]. Oncotarget, 2018, 9(21): 15616-15634.
doi: 10.18632/oncotarget.v9i21
|
| [16] |
Liu X, Meng L, Song WZ, et al. Efficacy of toothpaste containing polylysine and funme peptide on oral microbiome and oral health[J]. Int Dent J, 2025, 75(2): 1068-1080.
doi: 10.1016/j.identj.2024.11.017
pmid: 39809651
|
| [17] |
Zhang R, Xu LJ, Dong CM. Antimicrobial peptides: An overview of their structure, function and mechanism of action[J]. Protein Pept Lett, 2022, 29(8): 641-650.
doi: 10.2174/0929866529666220613102145
pmid: 35702771
|
| [18] |
Lyu YF, Tan MS, Xue M, et al. Broad-spectrum hybrid antimicrobial peptides derived from PMAP-23 with potential LPS binding ability[J]. Biochem Pharmacol, 2023, 210: 115500.
doi: 10.1016/j.bcp.2023.115500
|
| [19] |
Frazão DR, Matos-Souza JM, Dos Santos VRN, et al. Minocycline reduces alveolar bone loss and bone damage in Wistar rats with experimental periodontitis[J]. PLoS One, 2024, 19(10): e0309390.
doi: 10.1371/journal.pone.0309390
|
| [20] |
Lee YS, Feng CW, Peng MY, et al. Antiosteoporosis effects of a marine antimicrobial peptide pardaxin via regulation of the osteogenesis pathway[J]. Peptides, 2022, 148: 170686.
doi: 10.1016/j.peptides.2021.170686
|
| [21] |
Patil RT, Dhadse PV, Wankhede AN, et al. Role of antimicrobial peptides in periodontal health and disease-A review[J]. J Pharm Bioallied Sci, 2025, 17(Suppl 1): S172-S174.
doi: 10.4103/jpbs.jpbs_1668_24
pmid: 40511148
|
| [22] |
吴梦静, 张大启, 李其富, 等. 抗菌肽LL-37与自身免疫性疾病的研究进展[J]. 中国免疫学杂志, 2025, 41(3): 756-759.
|
| [23] |
Liang J, Chen J, Ye Z, et al. Cathelicidin LL-37 improves bone metabolic balance in rats with ovariectomy-induced osteoporosis via the Wnt/beta-catenin pathway[J]. Physiol Res, 2022, 71(3): 369-377.
pmid: 35616038
|
| [24] |
Li LJ, Jiang H, Chen RX, et al. Human β-defensin 3 gene modification promotes the osteogenic differentiation of human periodontal ligament cells and bone repair in periodontitis[J]. Int J Oral Sci, 2020, 12(1): 13.
doi: 10.1038/s41368-020-0078-6
|
| [25] |
Zhou J, Li LJ, Cui D, et al. Effects of gold nanoparticles combined with human β-defensin 3 on the alveolar bone loss of periodontitis in rat[J]. Biomed Eng Online, 2021, 20(1): 115.
doi: 10.1186/s12938-021-00954-9
pmid: 34819109
|
| [26] |
吴奇蓉, 雷晨, 汤春波, 等. 钛表面芬母多肽涂层的构建及其抗菌性能探究[J]. 口腔医学, 2022, 42(7):582-586.
|
| [27] |
Yu SP, Zhang Q, Hu ML, et al. Study on optimizing novel antimicrobial peptides with bifunctional activity to prevent and treat peri-implant disease[J]. Antibiotics (Basel), 2022, 11(11): 1482.
|
| [28] |
Almazin SM, Dziak R, Andreana S, et al. The effect of doxycycline hyclate, chlorhexidine gluconate, and minocycline hydrochloride on osteoblastic proliferation and differentiation in vitro[J]. J Periodontol, 2009, 80(6): 999-1005.
doi: 10.1902/jop.2009.080574
pmid: 19485832
|
| [29] |
Zhang T, Qiu YQ, Song JL, et al. Electrosprayed minocycline hydrochloride-loaded microsphere/SAIB hybrid depot for periodontitis treatment[J]. Drug Deliv, 2021, 28(1): 620-633.
doi: 10.1080/10717544.2021.1902020
pmid: 33779441
|